Prevalence of human herpesvirus-8 infection in HIV-positive patients with and without Kaposi's sarcoma in Hungary

FEMS Immunol Med Microbiol. 2005 Feb 1;43(2):265-8. doi: 10.1016/j.femsim.2004.08.012.

Abstract

Human herpesvirus-8 (HHV-8) infection of 130 Hungarian HIV-positive individuals with or without Kaposi's sarcoma was investigated from 158 serum and 122 peripheral blood samples using anti-latency-associated nuclear antigen (LANA) indirect immunofluorescence assay (IFA), recombinant orf65 and orfK8.1 antigen enzyme-linked immunosorbent assays (ELISAs), Western blot assays and orf26 specific nested polymerase chain reaction (PCR). The overall prevalence of HHV-8 infection was found to be 31.5% (41/130) among the Hungarian HIV-positive patients. This seroprevalence rate is 7-11-fold higher than that of healthy HIV-negative blood donors in Hungary. The highest prevalence of HHV-8 infection (36.1%, 35/97) was observed in homo- or bisexual patients. Similar to the serologic results, HHV-8 DNA was not always detectable in all serial samples previously shown to be positive for HHV-8 DNA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antibodies, Viral / blood
  • Antigens, Viral / immunology
  • Blotting, Western
  • Child
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Fluorescent Antibody Technique, Indirect
  • Genes, Viral
  • HIV Infections / complications*
  • Herpesviridae Infections / complications*
  • Herpesviridae Infections / epidemiology*
  • Herpesvirus 8, Human / immunology
  • Herpesvirus 8, Human / isolation & purification*
  • Humans
  • Hungary / epidemiology
  • Male
  • Middle Aged
  • Nuclear Proteins / immunology
  • Polymerase Chain Reaction
  • Prevalence
  • Recombinant Proteins
  • Risk Factors
  • Sarcoma, Kaposi / epidemiology*
  • Sexual Behavior
  • Viral Proteins / immunology

Substances

  • Antibodies, Viral
  • Antigens, Viral
  • Nuclear Proteins
  • ORF65 protein, human herpesvirus 8
  • Recombinant Proteins
  • Viral Proteins
  • latency-associated nuclear antigen